These genes may accumulate somatic mutations in conjunction with mutations and/or amplifications of PIK3CA and AKT3, as well as deletions or mutations of PTEN, TSC1, and INPP4B in the PI3K/mTOR pathway, although not in the majority of breast cancers (BCs). This evidence concerns the gene PIK3CA and breast cancer.